| Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): D ata from randomized controlled trials M Monami, B Nreu, A Scatena, B Cresci, F Andreozzi, G Sesti, ... Diabetes, Obesity and Metabolism 19 (9), 1233-1241, 2017 | 197 | 2017 |
| Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized controlled trials I Dicembrini, B Nreu, A Scatena, F Andreozzi, G Sesti, E Mannucci, ... Acta diabetologica 54, 933-941, 2017 | 77 | 2017 |
| Glucagon-like peptide-1 receptor agonists and atrial fibrillation: a systematic review and meta-analysis of randomised controlled trials M Monami, B Nreu, A Scatena, S Giannini, F Andreozzi, G Sesti, ... Journal of Endocrinological Investigation 40, 1251-1258, 2017 | 59 | 2017 |
| Effectiveness and safety of a novel gel dressing in the management of neuropathic leg ulcers in diabetic patients: a prospective double-blind randomized trial L Abbruzzese, L Rizzo, G Fanelli, A Tedeschi, A Scatena, C Goretti, ... The international journal of lower extremity wounds 8 (3), 134-140, 2009 | 53 | 2009 |
| Short and medium‐term efficacy of sodium glucose co‐transporter‐2 (SGLT‐2) inhibitors: a meta‐analysis of randomized clinical trials M Monami, F Liistro, A Scatena, B Nreu, E Mannucci Diabetes, Obesity and Metabolism 20 (5), 1213-1222, 2018 | 47 | 2018 |
| Primary infrainguinal subintimal angioplasty in diabetic patients I Bargellini, P Petruzzi, A Scatena, R Cioni, A Cicorelli, C Vignali, L Rizzo, ... CardioVascular and Interventional Radiology 31, 713-722, 2008 | 47 | 2008 |
| Drug-eluting balloon versus drug-eluting stent for complex femoropopliteal arterial lesions: the DRASTICO study F Liistro, P Angioli, I Porto, K Ducci, G Falsini, G Ventoruzzo, L Ricci, ... Journal of the American College of Cardiology 74 (2), 205-215, 2019 | 45 | 2019 |
| Randomized controlled trial of acotec drug-eluting balloon versus plain balloon for below-the-knee angioplasty F Liistro, P Angioli, G Ventoruzzo, K Ducci, MR Reccia, L Ricci, G Falsini, ... Cardiovascular Interventions 13 (19), 2277-2286, 2020 | 44 | 2020 |
| Outcomes of three years of teamwork on critical limb ischemia in patients with diabetes and foot lesions A Scatena, P Petruzzi, M Ferrari, L Rizzo, A Cicorelli, R Berchiolli, ... The International Journal of Lower Extremity Wounds 11 (2), 113-119, 2012 | 36 | 2012 |
| Effectiveness of combined therapy with angiotensin-converting enzyme inhibitors and statins in reducing mortality in diabetic patients with critical limb ischemia: an … E Faglia, G Clerici, A Scatena, M Caminiti, V Curci, A Morabito, V Prisco, ... Diabetes research and clinical practice 103 (2), 292-297, 2014 | 29 | 2014 |
| Clinical profiles and quality of care of subjects with type 2 diabetes according to their cardiovascular risk: an observational, retrospective study B Pintaudi, A Scatena, G Piscitelli, V Frison, S Corrao, V Manicardi, ... Cardiovascular Diabetology 20, 1-7, 2021 | 28 | 2021 |
| Iloprost in the management of peripheral arterial disease in patients with diabetes mellitus. A Piaggesi, V Vallini, E Iacopi, A Tedeschi, A Scatena, C Goretti, L Rizzo Minerva cardioangiologica 59 (1), 101-108, 2011 | 25 | 2011 |
| Clinical outcomes of wide postsurgical lesions in the infected diabetic foot managed with 2 different local treatment regimes compared using a quasi-experimental study design … C Goretti, S Mazzurco, LA Nobili, S Macchiarini, A Tedeschi, F Palumbo, ... The international journal of lower extremity wounds 6 (1), 22-27, 2007 | 23 | 2007 |
| Autologous peripheral blood mononuclear cells for limb salvage in diabetic foot patients with no-option critical limb ischemia A Scatena, P Petruzzi, F Maioli, F Lucaroni, C Ambrosone, G Ventoruzzo, ... Journal of Clinical Medicine 10 (10), 2213, 2021 | 22 | 2021 |
| Use of nanotechnology-designed footsock in the management of preulcerative conditions in the diabetic foot: results of a single, blind randomized study B Elisa, M Silvia, D Valentina, R Loredana, T Anna, S Alessia, G Chiara, ... The international journal of lower extremity wounds 7 (2), 82-87, 2008 | 19 | 2008 |
| Severity of demographic and clinical characteristics, revascularization feasibility, major amputation, and mortality rate in diabetic patients admitted to a tertiary diabetic … E Faglia, G Clerici, A Scatena, M Caminiti, V Curci, M Prisco, V Prisco, ... Annals of vascular surgery 28 (7), 1729-1736, 2014 | 18 | 2014 |
| All-cause and cardiovascular mortality in a consecutive series of patients with diabetic foot osteomyelitis L Ricci, A Scatena, D Tacconi, G Ventoruzzo, F Liistro, L Bolognese, ... Diabetes research and clinical practice 131, 12-17, 2017 | 16 | 2017 |
| A randomized, open-label, controlled trial to evaluate the antimicrobial and surgical effect of CO2 laser treatment in diabetic infected foot ulcers: DULCIS (diabetic ulcer, CO … M Monami, A Scatena, S Zannoni, S Aleffi, C Mirabella, L Giannoni, ... Journal of Endocrinological Investigation 40, 985-989, 2017 | 16 | 2017 |
| Antimicrobial photodynamic therapy in infected diabetic foot ulcers: a multicenter preliminary experience M Monami, A Scatena, M Schlecht, R Lobmann, L Landi, L Ricci, ... Journal of the American Podiatric Medical Association 110 (1), 2020 | 14 | 2020 |
| A metastatic squamous cell carcinoma in a diabetic foot: case report A Scatena, V Zampa, G Fanelli, E Iacopi, A Piaggesi The International Journal of Lower Extremity Wounds 15 (2), 155-157, 2016 | 10 | 2016 |
